Autor:	B. Akyol Ersoy, K. Safak, L. Yanik, P.O. Thuresson, E. Erdogan-Ciftci
Rok vydání:	2019
Předmět:	medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health Pirfenidone Cost-effectiveness analysis medicine.disease Gastroenterology Idiopathic pulmonary fibrosis chemistry.chemical_compound chemistry Internal medicine medicine Nintedanib business medicine.drug
Zdroj:	Value in Health. 22:S851
ISSN:	1098-3015
DOI:	10.1016/j.jval.2019.09.2385
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::648e078aed01890013dcb690fc3aa026 https://doi.org/10.1016/j.jval.2019.09.2385 Zobrazit plný text záznamu Full Text from ScienceDirect